Boehringer Buys Antibody-Drug Conjugates Biotech NBE For €1.18bn

Second Acquisition In ROR1 Space In A Month

 
• By Kevin Grogan
Boehringer
NBE buy puts focus on Boehringer • Source: Shutterstock

More from Deals

More from Business